Progenta

CDB-4124 · Repros Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Progenta, covering 2014-06-30 to 2014-06-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata [Phase 1, Phase 2]